Jenburkt Pharmaceuticals lost 3.01% to Rs 407.90 at 14:13 IST on BSE, with the stock extending losses triggered by the company reporting reverse turnaround in Q1.
Meanwhile, the S&P BSE Sensex was up 5.92 points, or 0.02% at 31,652.38. The S&P BSE Small-Cap index was up 78.69 points, or 0.5% at 15,944.96.
On the BSE, 6,032 shares were traded on the counter so far as against the average daily volumes of 6,157 shares in the past one quarter. The stock had hit a high of Rs 419.90 and a low of Rs 404 so far during the day. The stock had hit a record high of Rs 572.50 on 4 November 2016 and a 52-week low of Rs 345 on 14 September 2016.
The stock had underperformed the market over the past one month till 30 August 2017, declining 15.87% compared with the Sensex's 2.05% fall. The scrip had, however, outperformed the market over the past one quarter gaining 2.05% as against the Sensex's 1.56% rise. The scrip had also outperformed the market over the past one year advancing 16.63% as against the Sensex's 11.66% rise.
The small-cap company has equity capital of Rs 4.65 crore. Face value per share is Rs 10.
Shares of Jenburkt Pharmaceuticals have tumbled 6.03% in two trading sessions, from its closing of Rs 434.10 on 29 August 2017, after the company during market hours yesterday, 30 August 2017, reported weak Q1 June 2017 results. The stock had dropped 3.12% to settle at Rs 420.55 yesterday, 30 August 2017.
Jenburkt Pharmaceuticals reported net loss of Rs 2.88 crore in Q1 June 2017, compared with net profit of Rs 1.95 crore in Q1 June 2016. Net sales fell 23.8% to Rs 16.99 crore in Q1 June 2017 over Q1 June 2016.
Jenburkt Pharmaceuticals is engaged in the manufacture of pharmaceutical formulations. The company offers prescription and over-the-counter drugs.
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
